ホーム > 山田 武史/ Yamada, Takeshi

山田 武史

Yamada, Takeshi

医学医療系 , 講師
Institute of Medicine , Assistant Professor

関連記事はまだありません。

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab Hasegawa, Naoyuki; Hoshiai, Sodai; Yamada, Takeshi; Takahashi, Nobuyuki (+7 著者) Irie, Toshiyuki
      Anticancer research 46: 3897 (2026) Semantic Scholar
  2. 2. Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST) Kito, Yosuke; Yamazaki, Kentaro; Shoji, Hirokazu; Yamada, Takeshi (+22 著者) Muro, Kei
      EUROPEAN JOURNAL OF CANCER 238: (2026) Semantic Scholar
  3. 3. Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial Hoshiai, Sodai; Yamada, Takeshi; Kobayashi, Mariko; Amano, Taishi (+4 著者) Irie, Toshiyuki
      Anticancer Research 46: 2053 (2026)
  4. 4. The primary results of a randomized phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus FTD/TPI for previously treated patients with advanced gastric or gastroesophageal junction adenocarcinoma (RETRIEVE study, WJOG 15822G). Takahashi, Naoki; Hara, Hiroki; Shoji, Hirokazu; Ando, Takayuki (+15 著者) Muro, Kei
      JOURNAL OF CLINICAL ONCOLOGY 44: 357 (2026) Semantic Scholar
  5. 5. Impact of university-led startup acceleration programs on research and development strategies and successful private funding in Japan Matsuda, Takaaki; Masuda, Noriyuki; Kojo, Kosuke; Noguchi, Hiroshi (+10 著者) Machino, Takeshi
      Translational and Regulatory Sciences 7: 120 (2025)
  6. 6. 乳癌患者におけるパクリタキセルによる末梢神 経障害とQOL：MICHEL 試験サブ解析 澤 文; 佐藤璃子; 松尾知平; 岡﨑舞 (+6 著者) 坂東裕子
      JSCOmeeting 第63回日本癌治療学会学術集会 (2025)
  7. 7. Paclitaxel‐induced Peripheral Neuropathy and Quality of Life: Sub‐analysis of the MICHEL Study Sawa, Aya; Sato, Riko; Matsuo, Tomohei; Okazaki, Mai (+6 著者) Bando, Hiroko
      Anticancer Research 45: 3827 (2025) Semantic Scholar
  8. 8. Association of concomitant proton pump inhibitor use with worse survival outcomes in patients with advanced gastric cancer receiving ramucirumab Kaneko, Takuya; Doki, Kosuke; Yamada, Takeshi; Uda, Masato (+3 著者) Homma, Masato
      British journal of clinical pharmacology (2025) Semantic Scholar
  9. 9. Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria Hoshiai, Sodai; Hasegawa, Naoyuki; Yamada, Takeshi; Takahashi, Nobuyuki (+6 著者) Irie, Toshiyuki
      Scientific reports 15: (2025) Semantic Scholar
  10. 10. The First Case of a Single-Dose, Intravenous Perampanel Administration for Early Postoperative Seizure Prophylaxis Sugii, Narushi; Yamada, Takeshi; Ishikawa, Eiichi
      CLINICAL CASE REPORTS 13: (2025) Semantic Scholar
  11. 11. Methods to Enhance Accessibility of Japanese Medical Literature in English Journals Kojo, Kosuke; Mathis, Bryan J.; Yamada, Takeshi; Nishiyama, HiroyukiMachino, Takeshi
      JMA JOURNAL Epub: (2024) Semantic Scholar
  12. 12. Impact of age and single heterozygous UGT1A1 on the safety and efficacy of first-line FOLFIRI or FOLFOXIRI in combination with ramucirumab (RAM) for metastatic colorectal cancer (mCRC): Subgroup analyses of WJOG9216G (RECAST) Shiraishi, K.; Kito, Y.; Shoji, H.; Yamada, T. (+15 著者) Muro, K.
      ANNALS OF ONCOLOGY 35: S440 (2024) Semantic Scholar
  13. 13. Update analysis of the randomized phase II study comparing FOLFIRI plus ramucirumab (RAM) versus FOLFOXIRI plus RAM as first-line treatment for patients with metastatic colorectal cancer: WJOG9216G (RECAST) Yamazaki, K.; Kito, Y.; Shoji, H.; Yamada, T. (+15 著者) Muro, K.
      ANNALS OF ONCOLOGY 35: S437 (2024) Semantic Scholar
  14. 14. Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Hamano, Jun; Higashibata, Takahiro; Kessoku, Takaomi; Kajiura, Shinya (+21 著者) Morita, Tatsuya
      Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42: JCO2400381 (2024) Semantic Scholar
  15. 15. 胃全摘術後の六君子湯投与において肝機能障害を認めた一例（会議録） 大内, 政輝; 嶋田, 沙織; 長崎 茜; 山田, 武史本間, 真人
      和漢医薬学会学術大会要旨集 41回: 95 (2024)
  16. 16. Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids Seyama, Yusuke; Sudo, Kazuhiro; Yamada, Takeshi; Tsuchiya, KiichiroNakamura, Yukio
      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 709: (2024) Semantic Scholar
  17. 17. Severe cytomegalovirus gastritis due to pembrolizumab-induced agranulocytosis Kobayashi, Mariko; Sawafuji, Taku; Yamada, Takeshi
      GASTROINTESTINAL ENDOSCOPY 99: (2024) Semantic Scholar
  18. 18. Subgroup analyses of the effect of ramucirumab in pretreatment with immune checkpoint inhibitor in RINDBeRG: A randomized clinical trial in third- or further-line treatment of gastric cancer. Kawabata, Ryohei; Sakai, Daisuke; Kadowaki, Shigenori; Tsuduki, Takao (+15 著者) Satoh, Taroh
      JOURNAL OF CLINICAL ONCOLOGY 42: 339 (2024) Semantic Scholar
  19. 19. Identification of a gene set that maintains tumorigenicity of the hepatocellular carcinoma cell line Li-7 Seyama, Yusuke; Sudo, Kazuhiro; Hirose, Suguru; Hamano, Yukako (+7 著者) Nakamura, Yukio
      HUMAN CELL 36: 2074 (2023) Semantic Scholar
  20. 20. Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis Seyama, Yusuke; Yamada, Takeshi; Suzuki, Hirosumi; Fukuda, Satoshi (+5 著者) Hyodo, Ichinosuke
      INTERNATIONAL CANCER CONFERENCE JOURNAL 12: 268 (2023) Semantic Scholar
1 2 3 4
  1. 1. 消化器内視鏡 小林, 真理子; 坂本, 琢; 小松, 義希; 秋山, 慎太郎; 山田, 武史; 山本, 祥之; 奈良坂, 俊明; 土屋, 輝一郎
    東京医学社 2024年3月
  2. 2. 消化器内視鏡 小林, 真理子; 坂本, 琢; 小松, 義希; 秋山, 慎太郎; 山田, 武史; 山本, 祥之; 奈良坂, 俊明; 土屋, 輝一郎
    東京医学社 2024年3月
  3. 3. YORi-SOUがんナーシング 入江佳子; 山田, 武史
    2022年12月
  4. 4. がんゲノム医療 結果報告書の読み方と患者への伝え方～エキスパートパネルの実際～ 山田, 武史; 坂東, 裕子; 関根, 郁夫
    株式会社医学と看護社 2020年5月 (ISBN: 9784909888105)
  5. 5. INTESTINE 山田, 武史; 金子剛; 溝上裕士
    日本メディカルセンター社 2017年11月
  6. 6. 大腸がんPerspective 山田, 武史; 兵頭一之介
    メディカルレビュー社 2017年
  7. 7. 消化器・肝臓内科 山田, 武史; 溝上裕士
    科学評論社 2017年
  8. 8. 次世代のがん治療薬・診断のための研究開発 山田,武史
    技術情報協会 2016年2月
  9. 9. 薬剤学 山田, 武史; 百 賢二; 鶴嶋英夫; 荒川義弘
    2016年
  10. 10. がん分子標的治療 山田, 武史; 森脇俊和
    メディカルレビュー社 2015年
  11. 11. 消化器の臨床 山田, 武史; 森脇俊和; 兵頭一之介
    ヴァン・メディカル社 2010年
  12. 12. 消化管Network 山田, 武史; 森脇俊和; 兵頭一之介
    朝日新聞社 2009年

 654 total views